ODT Technology
Advances in pharmaceutical technologies have consistently aimed to improve therapeutic efficacy, enhance patient compliance, and increase the safety of drug use. One of the most significant achievements in this field is the development of orally disintegrating tablets (ODTs). These dosage forms are designed to disintegrate rapidly upon contact with saliva, without the need for water, enabling easier administration and a faster onset of action.
Definition and Technical Characteristics of ODTs
According to pharmacopeial definitions, orally disintegrating tablets are solid dosage forms that typically disintegrate and dissolve on the tongue within less than 30 seconds, without the need for chewing or active swallowing. The key characteristics of this drug delivery system include the following:
- Very short disintegration time
- No need for water
- Minimal foreign body sensation in the mouth
- High patient acceptance
Scientific Basis and Mechanism of Action of ODTs
The performance of ODTs is based on the precise combination of specific excipients and appropriate tablet structural design. Upon contact with saliva, the following mechanisms are activated simultaneously:
- Rapid penetration of saliva into the tablet structure due to high porosity
- Swelling or rapid dissolution of superdisintegrants
- Disintegration of the tablet matrix
- Release of the active pharmaceutical ingredient
As a result of this process, the drug substance is released in the oral cavity within a short period of time. Depending on the nature of the drug, a portion may be absorbed through the oral mucosa, while the remainder is absorbed via the gastrointestinal tract.
Key Materials and Components in ODT Formulation
The formulation of orally disintegrating tablets requires the careful selection of raw materials. The main components include:
- Advanced superdisintegrants such as crospovidone, croscarmellose sodium, and sodium starch glycolate
- Soluble or porous fillers such as mannitol, which not only enhance disintegration but also provide a pleasant mouthfeel
- Flavoring agents and sweeteners to enhance patient acceptance
- Binders and lubricants used at controlled levels to maintain the mechanical integrity of the tablet
- Balancing the tablet’s physical strength with its disintegration speed is one of the main challenges in ODT design.
Pharmacokinetic and Clinical Advantages of ODTs
The use of ODT technology can offer multiple pharmacokinetic and clinical benefits, including:
A faster onset of action for drugs that are absorbed via the oral mucosa.
Reduced absorption delay compared to conventional tablets.
Improved treatment adherence in elderly patients and individuals with swallowing disorders.
Reduced anxiety associated with medication intake in patients who are sensitive to swallowing tablets.
Technological Challenges and Considerations
Despite their numerous advantages, the development of ODTs is associated with several challenges:
- High sensitivity to moisture, necessitating protective packaging (such as aluminum blisters)
- Dose limitations for certain active ingredients
- Complexity of the formulation and manufacturing processes
Overcoming these challenges requires specialized expertise, precise control of the manufacturing process, and the application of advanced pharmaceutical technologies.
Applications of ODT Technology in Sleep-Related Supplements and Medications
Melatonin is one of the compounds that is particularly well suited to ODT technology due to its need for a rapid onset of action and easy administration before sleep. The use of this technology in melatonin products enables more convenient bedtime use, reduced onset delay, and an improved user experience.
Orally disintegrating tablet (ODT) technology represents a significant advancement in oral drug delivery systems. By integrating principles of pharmaceutical engineering, careful selection of excipients, and advanced structural design, this technology has reduced the limitations of conventional dosage forms and improved the medication-taking experience. The application of this technology in products such as Melatonin Oroquick® reflects a shift toward innovative, patient-centered solutions in the pharmaceutical industry.


